Neoplasia endocrina múltiple (NEM) II

Home > Medical Reference > Encyclopedia (Spanish)

Toggle: English / Spanish

Services at the UM Medical Center


Contenido en el Idioma Espa±ol de University of Maryland Medical Center.

Neoplasia endocrina múltiple (NEM) II

Definición:

Es una enfermedad poco común que se transmite de padres a hijos (hereditaria) y se caracteriza por hiperactividad de la glándula tiroides, las glándulas suprarrenales y las glándulas paratiroides.

Nombres alternativos:

Síndrome de Sipple

Causas, incidencia y factores de riesgo:

La causa de la NEM II es un defecto en un gen llamado RET. Este defecto hace que muchos tumores aparezcan en la misma persona, pero no necesariamente al mismo tiempo. El tipo de tumor suprarrenal es un feocromocitoma y el tumor tiroideo es un carcinoma medular de la tiroides .

Esta enfermedad puede ocurrir a cualquier edad y afectar por igual a hombres y mujeres. El factor principal de riesgo es un antecedente familiar de NEM II.

Glándulas endocrinas

Glándulas endocrinas

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com